Pre-clinical trials of the Cancer Vaccine showed promising results in halting tumor growth and spread. The human trials will ...

Japan has launched clinical trials for a synthetic, universally compatible blood substitute, marking a potential breakthrough ...

Russia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innovative vaccine, tailored to individual tumor genetics using AI ...

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Researchers in gastroenterology and hepatology at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...

Following tests on apes and mice, a team of University of New Mexico (UNM) researchers are aiming to carry out human clinical trials for a vaccine that targets a brain protein associated with ...

Elon Musk 's Neuralink is gearing up to conduct a clinical study in UK. The research will explore how its advanced brain chips can help patients with severe paralysis, control digital and physical ...

Moderna, the first to start human testing of a COVID vaccine, began a phase 1 safety study of its candidate vaccine in a small group of healthy adults on March 16, 2020. Results from that study ...

Neuralink is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.

The Risks Of Using AI In Clinical Trials AI can streamline clinical trials, but it’s not without risks. AI should be used as an assistive tool for clinical trials, not a replacement for human ...